AN1
Click for more information
14.3% 0.8¢ anagenics limited

The securities of Cellmid Limited (the “Company”) will be placed...

  1. dsherwood
    307 Posts.
    clock Created with Sketch.
    09/12/13
    09:04
    Post #: 12673802
    The securities of Cellmid Limited (the “Company”) w
    ill be placed in Trading Halt Session
    State at the request of the Company, pending the re
    lease of an announcement by the
    Company. Unless ASX decides otherwise, the securities will remain in Trading Halt
    Session State until the earlier of the commencement
    of normal trading on Wednesday,
    11 December 2013 or when the announcement is released to the market
    CDY Price at posting: 3.3¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

RDN If you thought lithium was dead, think again. The Pilbara will be central to the next upswing
right-arrow Created with Sketch.
BOT US FDA approves Botanix Pharma's excessive underarm sweat drug
right-arrow Created with Sketch.
NEWS Chris Judd's Talk Ya Book: Tracking Life360 on a journey to the stars
right-arrow Created with Sketch.
AML Cultural heritage agreement puts Walford Creek exploration back on the map
right-arrow Created with Sketch.
GYG Guzman Y Gomez shot up nearly 40% in first hour of trades. Can it last?
right-arrow Created with Sketch.
CC9 Chariot Corporation marches forward with discovery-level drill program in Wyoming, USA
right-arrow Created with Sketch.
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
(20min delay)
Last
0.8¢ 		Change
0.001(14.3%) 		Mkt cap ! $3.691M
Open High Low Value Volume
0.8¢ 0.8¢ 0.8¢ $1.92K 240K

Buyers (Bids)

No. Vol. Price($)
3 493225 0.7¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 615000 4
View Market Depth
Last trade - 10.07am 21/06/2024 (20 minute delay) ?
AN1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.